XML 27 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Treasury Stock, At Cost
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Europe
Europe
Accumulated Other Comprehensive Income (Loss)
France
France
Accumulated Other Comprehensive Income (Loss)
Balances (in shares) at Dec. 31, 2016   36,924,000                
Balances at Dec. 31, 2016 $ 214.4 $ 0.4 $ 185.5 $ (23.9) $ 73.1 $ (20.7)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 1.6   1.6              
Issuance of restricted stock (in shares)   68,000                
Issuance of restricted stock 0.0   (0.8) 0.8            
Stock withheld for employee taxes (in shares)   (48,000)                
Stock withheld for employee taxes (0.8)   (0.3) (0.5)            
Cancellation of restricted shares (in shares)   (8,000)                
Cancellation of restricted shares (0.1)   0.0 (0.1)            
Proceeds from issuance of common stock (in shares)   158,000                
Proceeds from issuance of common stock 2.4   0.5 1.9            
Dividends (68.7)       (68.7)          
Discontinued European entities cumulative translation adjustment             $ 14.4 $ 14.4    
Change in cumulative translation adjustment 8.2         8.2        
Net income 40.4       40.4          
Balances (in shares) at Dec. 31, 2017   37,094,000                
Balances at Dec. 31, 2017 211.8 $ 0.4 186.5 (21.8) 44.8 1.9        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 2.8   2.8              
Issuance of restricted stock (in shares)   117,000                
Issuance of restricted stock 0.0   (1.7) 1.7            
Stock withheld for employee taxes (in shares)   (62,000)                
Stock withheld for employee taxes (1.9)   0.0 (1.9)            
Proceeds from issuance of common stock (in shares)   419,000                
Proceeds from issuance of common stock 5.4   (0.6) 6.0            
Dividends $ (297.1)       (297.1)          
Repurchase of treasury shares (in shares) (232,550) (233,000)                
Repurchase of treasury shares $ (9.1)     (9.1)            
Discontinued European entities cumulative translation adjustment                 $ 4.1 $ 4.1
Change in cumulative translation adjustment (3.0)         (3.0)        
Net income 224.7       224.7          
Balances (in shares) at Dec. 31, 2018   37,335,000                
Balances at Dec. 31, 2018 137.7 $ 0.4 187.0 (25.1) (27.6) 3.0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 5.4   5.4              
Issuance of restricted stock (in shares)   109,000                
Issuance of restricted stock 0.0   (1.8) 1.8            
Stock withheld for employee taxes (in shares)   (39,000)                
Stock withheld for employee taxes (0.9)   (0.9)            
Proceeds from issuance of common stock (in shares)   230,000                
Proceeds from issuance of common stock 2.1   (1.7) 3.8            
Dividends (18.1)       (18.1)          
Issuance of shares under employee stock purchase plan (shares)   44,000                
Issuance of shares under employee stock purchase plan 0.8   0.8              
Change in cumulative translation adjustment 0.0         0.0        
Net income 48.5       48.5          
Balances (in shares) at Dec. 31, 2019   37,679,000                
Balances at Dec. 31, 2019 $ 175.5 $ 0.4 $ 189.7 $ (20.4) $ 2.8 $ 3.0